Importantly, TGR5 activated the cAMP-STAT3/STAT6 axis to promote M2 polarization of tumor-associated macrophages and suppress CD8+ T-cell anti-tumor immunity in non-small-cell lung cancer mouse models [197]. The gene discussed is CD8A; the disease is neoplasm.